azathioprine has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silva, J | 1 |
Brito, BS | 1 |
Silva, INN | 1 |
Nóbrega, VG | 1 |
da Silva, MCSM | 1 |
Gomes, HDN | 1 |
Fortes, FM | 1 |
Pimentel, AM | 1 |
Mota, J | 1 |
Almeida, N | 1 |
Surlo, VC | 1 |
Lyra, A | 1 |
Rocha, R | 1 |
Santana, GO | 1 |
Moseley, RH | 1 |
Manoogian, B | 1 |
Shehab, T | 1 |
Saint, S | 1 |
2 other studies available for azathioprine and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
Topics: Adult; Azathioprine; Cholelithiasis; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Fe | 2019 |
Clinical problem-solving. An intricate interplay.
Topics: alpha 1-Antitrypsin; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Diagnosis, Differential | 2012 |